Mounjaro 5mg

Forms and dosages

Mounjaro is administered once weekly by subcutaneous injection in the abdomen, thigh or upper arm. According to the prescribing information, treatment starts at 2.5mg per week as a tolerability dose for four weeks, then escalates by 2.5mg every four weeks to a maintenance dose of 5, 10 or 15mg, selected by the prescriber. Injection day can be changed if the new day is at least three days from the previous one. Pens must be stored refrigerated before first use.

Indications

The medication is indicated in adults with type 2 diabetes mellitus, alone or in combination with other antidiabetic agents, to improve glycaemic control. It is not indicated for type 1 diabetes or diabetic ketoacidosis. The same molecule is approved under a separate brand name for chronic weight management in adults with obesity or with overweight and at least one weight-related comorbidity. According to the prescribing information, treatment must be initiated and supervised by a clinician.